196 related articles for article (PubMed ID: 1371448)
1. Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex.
Campbell PG; Novak JF; Yanosick TB; McMaster JH
Endocrinology; 1992 Mar; 130(3):1401-12. PubMed ID: 1371448
[TBL] [Abstract][Full Text] [Related]
2. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C; Silve C; Rosato R; Segovia B; Binoux M
Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells.
Campbell PG; Novak JF
J Cell Physiol; 1991 Nov; 149(2):293-300. PubMed ID: 1721071
[TBL] [Abstract][Full Text] [Related]
4. [Interactions of insulin-like growth factors (IGF) and their binding proteins with the plasminogen/plasmin activator system in cultured osteoblasts].
Lalou C; Silve C; Segovia B; Binoux M
Ann Endocrinol (Paris); 1994; 55(2):103-7. PubMed ID: 7802427
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
Irwin JC; Dsupin BA; Giudice LC
J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM
Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
8. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-I.
Grimes RW; Hammond JM
Endocrinology; 1994 Jan; 134(1):337-43. PubMed ID: 7506209
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
Neely EK; Rosenfeld RG
Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
[TBL] [Abstract][Full Text] [Related]
11. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
12. Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol.
Kleinman D; Karas M; Roberts CT; LeRoith D; Phillip M; Segev Y; Levy J; Sharoni Y
Endocrinology; 1995 Jun; 136(6):2531-7. PubMed ID: 7750475
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
Angelloz-Nicoud P; Harel L; Binoux M
Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
[TBL] [Abstract][Full Text] [Related]
15. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
Angelloz-Nicoud P; Binoux M
Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins.
McCusker RH; Busby WH; Dehoff MH; Camacho-Hubner C; Clemmons DR
Endocrinology; 1991 Aug; 129(2):939-49. PubMed ID: 1713163
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.
Fowlkes J; Freemark M
Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096
[TBL] [Abstract][Full Text] [Related]
18. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.
Cohen P; Peehl DM; Lamson G; Rosenfeld RG
J Clin Endocrinol Metab; 1991 Aug; 73(2):401-7. PubMed ID: 1713219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
